Related Experiment Videos
Proteomic strategies in bladder cancer
J E Celis1, H Wolf, M Ostergaard
1Department of Medical Biochemistry and Danish Centre for Human Genome Research, Aarhus University. jec@biokemi.au.dk
IUBMB Life
|May 3, 2000
Summary
This study uses proteomic technologies and immunowalking to identify changes in bladder cancer cells. The approach helps understand bladder cancer progression in vivo, even with complex tumor samples.
Area of Science:
- Oncology
- Proteomics
- Biochemistry
Background:
- Bladder cancer is a field disease, affecting large areas of the bladder lining.
- Identifying phenotypic changes in urothelium is crucial for understanding invasive bladder cancer.
- Current methods face challenges with heterogeneous tumor biopsy materials.
Purpose of the Study:
- To review a strategy for identifying urothelial phenotypic changes in invasive bladder cancer.
- To apply proteomic technologies and immunowalking to study bladder cancer.
- To investigate bladder cancer under conditions mimicking the in vivo situation.
Main Methods:
- Utilizing proteomic technologies to identify differentially expressed proteins in tumors versus normal urothelium.
- Employing immunowalking with specific antibodies to stain cryostat sections of cystectomies.
- Analyzing serial sections from patients with invasive bladder cancer.
Main Results:
- Proteomic technologies successfully revealed differentially expressed proteins.
- Immunowalking enabled visualization of protein distribution in tumor tissues.
- The study demonstrated feasibility of studying bladder cancer in a near in vivo setting.
Conclusions:
- The combined proteomic and immunowalking strategy is effective for studying bladder cancer.
- This approach can be adapted for various types of bladder cancer.
- It provides insights into the spectrum of urothelial abnormalities in bladder cancer patients.